02/12/2014
KURMA Partners invests in Xeltis, a leading regenerative medicine company with first product targeting orphan and severe cardiac malformations
Kurma Partners, a key European player in the financing of Innovation in Healthcare, announces its investment in Xeltis, a private Swiss/Dutch [...]
